Cell Impact AB Cash Flow Conversion Efficiency
Cell Impact AB cash flow conversion efficiency. Based on the latest financial reports, Cell Impact AB (CI) has a cash flow conversion efficiency ratio of -0.104x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-19.56 Million ≈ $-2.10 Million USD) by net assets (Skr187.48 Million ≈ $20.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cell Impact AB (2012–2024)
Cash flow conversion efficiency of Cell Impact AB from 2012 to 2024. This chart illustrates how Cell Impact AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Cell Impact AB (CI) stock price for real-time trading data and today's change.
Cell Impact AB Cash Flow Conversion Ratio Explained
Cell Impact AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cell Impact AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cell Impact AB ranked by their cash flow conversion efficiency. Also see CI company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MEMIONTEC HOLDINGS LTD
F:8900
|
N/A |
|
M.T.I Wireless Edge Ltd
LSE:MWE
|
-0.003x |
|
Lilium NV
NASDAQ:LILM
|
0.005x |
|
Prostatype Genomics AB
ST:PROGEN
|
-0.234x |
|
SpectraCure AB
ST:SPEC
|
-0.048x |
|
IMAGE POWER S.A. ZY -10
F:7UQ
|
0.628x |
|
Infinitum Copper Corp
V:INFI
|
-0.132x |
|
Panthera Resources PLC
LSE:PAT
|
-0.329x |
Annual Cash Flow Conversion Efficiency for Cell Impact AB (2012–2024)
The table below shows the annual cash flow conversion efficiency of Cell Impact AB from 2012 to 2024. Review CI FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr219.08 Million ≈ $23.58 Million |
Skr-62.23 Million ≈ $-6.70 Million |
-0.284x | +14.65% |
| 2023-12-31 | Skr303.37 Million ≈ $32.65 Million |
Skr-100.97 Million ≈ $-10.87 Million |
-0.333x | -1.91% |
| 2022-12-31 | Skr324.35 Million ≈ $34.90 Million |
Skr-105.93 Million ≈ $-11.40 Million |
-0.327x | +45.88% |
| 2021-12-31 | Skr142.62 Million ≈ $15.35 Million |
Skr-86.08 Million ≈ $-9.26 Million |
-0.604x | -156.00% |
| 2020-12-31 | Skr201.89 Million ≈ $21.73 Million |
Skr-47.59 Million ≈ $-5.12 Million |
-0.236x | +74.10% |
| 2019-12-31 | Skr45.05 Million ≈ $4.85 Million |
Skr-41.01 Million ≈ $-4.41 Million |
-0.910x | +59.09% |
| 2018-12-31 | Skr19.14 Million ≈ $2.06 Million |
Skr-42.57 Million ≈ $-4.58 Million |
-2.225x | -224.24% |
| 2017-12-31 | Skr23.09 Million ≈ $2.48 Million |
Skr-15.84 Million ≈ $-1.70 Million |
-0.686x | -218.20% |
| 2016-12-31 | Skr41.38 Million ≈ $4.45 Million |
Skr-8.92 Million ≈ $-960.18K |
-0.216x | +90.92% |
| 2015-12-31 | Skr2.34 Million ≈ $251.78K |
Skr-5.56 Million ≈ $-598.14K |
-2.376x | -233.57% |
| 2014-12-31 | Skr8.22 Million ≈ $884.78K |
Skr-5.86 Million ≈ $-630.13K |
-0.712x | -45.82% |
| 2013-12-31 | Skr16.08 Million ≈ $1.73 Million |
Skr-7.86 Million ≈ $-845.36K |
-0.488x | +89.46% |
| 2012-12-31 | Skr1.68 Million ≈ $181.13K |
Skr-7.80 Million ≈ $-839.57K |
-4.635x | -- |
About Cell Impact AB
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company offers production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was inc… Read more